Virginia Commonwealth University Health System Gastroenterology

Topics

• Liver Disease Diagnosis and Treatment 734
• Liver Disease and Transplantation 610
• Hepatitis C virus research 281
• Alcohol Consumption and Health Effects 91
• Hepatitis B Virus Studies 79
• Pediatric Hepatobiliary Diseases and Treatments 76
• Liver Diseases and Immunity 74
• Drug Transport and Resistance Mechanisms 69
• Hepatocellular Carcinoma Treatment and Prognosis 61
• Organ Transplantation Techniques and Outcomes 58
• Inflammatory Bowel Disease 54
• Clostridium difficile and Clostridium perfringens research 46

Most cited

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

   Journal of hepatology · 2023 · 2,696 citations · Arun Sanyal

2. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

   Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Arun Sanyal

3. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

   The New England journal of medicine · 2024 · 1,637 citations · Arun Sanyal

4. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.

   Hepatology (Baltimore, Md.) · 2023 · 2,087 citations · Shadab Siddiqui

5. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

   The New England journal of medicine · 2025 · 750 citations · Arun Sanyal

6. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.

   The New England journal of medicine · 2024 · 761 citations · Arun Sanyal

7. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.